# Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia

> **NCT03062631** · — · NO_LONGER_AVAILABLE · sponsor: **Ricardo Maselli**

## Conditions studied

- Congenital Myasthenic Syndrome

## Interventions

- **DRUG:** 3,4-Diaminopyridine

## Key facts

- **NCT ID:** NCT03062631
- **Lead sponsor:** Ricardo Maselli
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2023-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03062631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03062631, "Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03062631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*